Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 1,348,635 shares, a growth of 979.7% from the September 30th total of 124,913 shares. Based on an average trading volume of 837,048 shares, the short-interest ratio is currently 1.6 days. Approximately 0.1% of the company’s shares are short sold.
Coloplast A/S Price Performance
Shares of OTCMKTS:CLPBY opened at $7.17 on Wednesday. The business has a 50-day moving average price of $6.80 and a 200 day moving average price of $6.84. Coloplast A/S has a 12-month low of $5.64 and a 12-month high of $9.70.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10. The company had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.11 billion. Equities analysts predict that Coloplast A/S will post 0.40 earnings per share for the current fiscal year.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
See Also
- Five stocks we like better than Coloplast A/S
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
